Health Plan Weekly

CVS Beats 4Q Wall Street Estimates as Aetna Business Stabilizes

  • Feb 14
    Popup Image

    Feb 14, 2025

    After a tumultuous several months that culminated in the ouster of former CEO Karen Lynch, CVS Health Corp.’s fourth-quarter 2024 results beat Wall Street consensus estimates. And while the company reported lower year-over-year operating income, executives said the struggling Aetna business is finally stabilizing. 

    The company’s adjusted earnings per share (EPS) for the fourth quarter came to $1.91, well above the consensus of 91 cents. Medical loss ratio (MLR) was 94.8%, which was lower (better) than the 95.5% guidance. And CVS posted revenue of $97.7 billion, beating the $97.1 billion consensus. 

    Read more
      • Health Plan Weekly
    © 2024 MMIT

    • Jill Drachenberg

    Jill has been a reporter and editor since 2005, mainly focusing on business and health care. Before joining AIS Health, she was an editor for Relias Media (formerly AHC Media), focusing on topics such as case management, medical ethics, risk management, infection control, hospital management, and contraceptive technology. She has a B.A. in journalism from Georgia State University.

    Back to Health Plan Weekly

Related Posts

The Latest
Premium Categories
Meet Our Reporters

Lauren Flynn Kelly

Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage

View Lauren Flynn Kelly's Profile

Angela Maas

Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access

View Angela Maas's Profile

Leslie Small

Managing Editor, Health Plan Weekly and Radar on Drug Benefits

View Leslie Small's Profile

Tim Casey

Reporter, Health Plan Weekly and Radar on Drug Benefits

View Tim Casey’s Profile

Carina Belles

Reporter, Radar on Medicare Advantage and Spotlight on Market Access

View Carina Belles's Profile

Jinghong Chen

Reporter, Health Plan Weekly and Radar on Drug Benefits

View Jinghong Chen's Profile

Jill Drachenberg

Reporter, Health Plan Weekly and Radar on Drug Benefits

View Jill Drachenberg's Profile

Meet Our Reporters

Lauren Flynn Kelly

Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage

View Lauren Flynn Kelly's Profile

Angela Maas

Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access

View Angela Maas's Profile

Leslie Small

Managing Editor, Health Plan Weekly and Radar on Drug Benefits

View Leslie Small's Profile

Tim Casey

Reporter, Health Plan Weekly and Radar on Drug Benefits

View Tim Casey’s Profile

Carina Belles

Reporter, Radar on Medicare Advantage and Spotlight on Market Access

View Carina Belles's Profile

Jinghong Chen

Reporter, Health Plan Weekly and Radar on Drug Benefits

View Jinghong Chen's Profile

Jill Drachenberg

Reporter, Health Plan Weekly and Radar on Drug Benefits

View Jill Drachenberg's Profile

Tags
Financial Results
Stock Performance
Medicare Advantage
Health Care Utilization
×

PREMIUM CONTENT AND PREMIUM INSIGHTS

To gain access to this article you need to have a Premium Subscription.
Click the link below to access today!